Market LIVE
Published markets; coverage varies by country
Product profile · United States

ARISTADA

 ·  Patent Litigation & Settlement History ↓

IngredientARIPIPRAZOLE LAUROXIL
Application typeNDA
Application207533
Product002
Dosage formSUSPENSION, EXTENDED RELEASE
RouteINTRAMUSCULAR
Strength662MG/2.4ML (275.83MG/ML)
Approval date2015-10-05
Marketing statusPrescription
Status event—
ApplicantALKERMES INC
Product source

Current GenericRadar decision

Year2030
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2030-10-26
Patent anchor2030-10-26
Exclusivity anchor2020-10-05
Protection date—
First Final ANDA—
Status event—

POST_ANCHOR_RIGHTS

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
101129032030-06-24DS/U U-543YNTRUE_DS
———
87962762030-06-24U U-543NYDS_EQUIVALENT
———
84315762030-10-26DS —YNTRUE_DS
———
102264582032-03-19U U-543NNU
———
90348672032-11-07DP/U U-543NNDP
———
126293662032-12-06DP/U U-764NNDP
———
110970062033-09-19DP/U U-764NNDP
———
123110272033-09-19DP/U U-543NNDP
———
91936852033-10-24DP/U U-543NNDP
———
119694692034-04-06DP —NNDP
———
102386512035-03-19U U-2402NNU
———
108139282035-03-19U U-2983NNU
———
114066322035-03-19U U-2402NNU
———
126538222035-03-19U U-2402NNU
———
94521312035-03-19U U-2402NNU
———
95267262035-03-19DP —NNDP
———
112731582039-04-06U U-543NNU
———
122513812039-04-06U U-543NNU
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (1)
TypeDateRoleBasisSource
REGULATORY_STATUS2030-10-26CANONICAL_DECISIONPOST_ANCHOR_RIGHTSSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.